<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04108169</url>
  </required_header>
  <id_info>
    <org_study_id>20190926</org_study_id>
    <nct_id>NCT04108169</nct_id>
  </id_info>
  <brief_title>Association Between S-LAAO and Adverse Cardiovascular Events Among Patients Undergoing Coronary Artery Bypass Grafting.</brief_title>
  <official_title>A Chinese Registry to Evaluate the Association of Surgical Left Atrial Appendage Occlusion vs No Receipt of S-LAAO With Adverse Cardiovascular Events Among Petients Undergoing Coronary Artery Bypass Grafting.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Institute of Heart, Lung and Blood Vessel Diseases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Institute of Heart, Lung and Blood Vessel Diseases</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, single-center, randomized, active controlled, clinical trail to assess
      the efficacy and safety of surgical closure of left atrial appendage (LAA) in patients
      undergoing coronary artery bypass graft.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2019</start_date>
  <completion_date type="Anticipated">January 2023</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause death</measure>
    <time_frame>3 year after discharge (These data is collected during follow-up visit at in-hospital)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Atrial fibrillation</measure>
    <time_frame>3 year after discharge (These data is collected during follow-up visit at in-hospital)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of ischemic stroke, thromboembolism and all death</measure>
    <time_frame>3 year after discharge (These data is collected during follow-up visit at in-hospital)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Heart Surgery</condition>
  <arm_group>
    <arm_group_label>Active Comparator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Comparator</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left atrial appendage occlusion surgery</intervention_name>
    <description>CABG according to indications in the current guidelines on myocardial revascularization including surgical closure of left atrial appendage</description>
    <arm_group_label>Active Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject undergoing coronary artery bypass grafting according to clinical indications;

          2. Age is more than 18 and less than 80 years old;

          3. Male and non pregnancy female;

          4. Subject understands study requirements and agrees to sign an informed consent from
             prior to study procedures.

        Exclusion Criteria:

          1. Pregnancy female;

          2. Participate in other clinical trial in the last 1 month.

          3. Subject doesn't agree to sign an informed consent from prior to study procedures.

          4. Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.

          5. New York Heart Association (NYHA) Class IV heart failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ping Li, PHD</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Anzhen Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yulin Li, PHD</last_name>
    <phone>86-010-64426153</phone>
    <email>lyllyl_1111@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ping Li, PHD</last_name>
    <email>13520112185@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Anzhen Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>ke-xu Yang</last_name>
      <phone>86-010-64426153</phone>
      <email>EC@anzhenGCP.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 26, 2019</study_first_submitted>
  <study_first_submitted_qc>September 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2019</study_first_posted>
  <last_update_submitted>September 27, 2019</last_update_submitted>
  <last_update_submitted_qc>September 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary artery bypass graft</keyword>
  <keyword>Left Atrial Appendage Occlusion</keyword>
  <keyword>stroke</keyword>
  <keyword>prevention</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

